Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing Florida, New Jersey, New York, and Pennsylvania, removed the separate state location subsections, and updated the page to revision v3.3.3 with the HHS Vulnerability Disclosure link removed.
    Difference
    0.6%
    Check dated 2025-12-23T08:20:16.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision: v3.3.2 updated from v3.3.1; this is a minor site version change with no impact on study content or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:36:54.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision label at the bottom of the page footer updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:42:45.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    A site-wide banner about potential delays due to government funding and NIH operating status has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:21:36.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The two screenshots show only cosmetic/layout differences with no substantive changes to the study details, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T00:56:18.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Major update: alerts about government funding status and a new version v3.2.0. Deletion of v3.1.0 indicates the version refresh.
    Difference
    3%
    Check dated 2025-10-05T08:21:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.